The Incidence and Risk Factors of De Novo Skin Cancer in the Liver Transplant Recipients

Background: Liver transplantation (LT) increases the risk of de novo malignancies including skin cancers. However, risk factors for this type of cancers have not been well studied.Objective: To determine the incidence of skin cancer in LT recipients, and to identify the risk factors of this type of...

Full description

Bibliographic Details
Main Authors: JM Modaresi Esfeh, M Pagadala, R Lopez, A Tabba, D Dalal, IA Hanouneh, B Eghtesad, NN Zein
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2012-10-01
Series:International Journal of Organ Transplantation Medicine
Subjects:
Online Access:http://home.sums.ac.ir/~habibzaf/ojs/index.php/IJOTM/article/view/135/238
_version_ 1818303867281997824
author JM Modaresi Esfeh
M Pagadala
R Lopez
A Tabba
D Dalal
IA Hanouneh
B Eghtesad
NN Zein
author_facet JM Modaresi Esfeh
M Pagadala
R Lopez
A Tabba
D Dalal
IA Hanouneh
B Eghtesad
NN Zein
author_sort JM Modaresi Esfeh
collection DOAJ
description Background: Liver transplantation (LT) increases the risk of de novo malignancies including skin cancers. However, risk factors for this type of cancers have not been well studied.Objective: To determine the incidence of skin cancer in LT recipients, and to identify the risk factors of this type of cancer.Methods: We identified all adult patients who underwent LT and developed de novo skin cancer post-LT at our institution between 1996 and 2009. We excluded the patients with history of skin cancer prior to LT. We also studied a control group of patients who underwent LT during the same period but did not develop skin cancer; the control group was matched (1:2) for age, gender and geographical place of residence.Results: Over a median (IQR) follow-up of 41.5 (18.0, 98.6) months, 23 (2.3%) of 998 patients developed skin cancer post-LT, of whom 10 were identified with squamous cell carcinoma, 9 with basal cell carcinoma and 4 with melanoma. After adjusting the confounding variables, subjects who had combined liver/kidney transplant had 22 (95% CI: 5.1–99) times higher hazard of skin cancer compared to subjects with LT alone. Furthermore, patients who had non-skin cancer prior to LT had 23 (95% CI: 8.6–60) times higher hazard developing skin cancer after the transplant. Patients with history of alcohol consumption, as the underlying etiology of liver disease, had 4 (95% CI: 1.2–12.9) times higher hazard of developing skin cancer after transplantation. Type or duration of immunosuppression was not associated with increased risk of skin cancer post-LT. The post-LT survival outcome was not affected by the development of de novo skin cancer post-LT.Conclusion: Skin cancer is relatively common in LT recipients and should be monitored, particularly in patients with a history of pretransplant malignancy, recipients of combined liver and kidney transplant or having alcoholic cirrhosis as the underlying cause of liver disease.
first_indexed 2024-12-13T06:01:37Z
format Article
id doaj.art-f858ace2be834c5bb1cd8539cc5890e2
institution Directory Open Access Journal
issn 2008-6490
2008-6482
language English
last_indexed 2024-12-13T06:01:37Z
publishDate 2012-10-01
publisher Shiraz University of Medical Sciences
record_format Article
series International Journal of Organ Transplantation Medicine
spelling doaj.art-f858ace2be834c5bb1cd8539cc5890e22022-12-21T23:57:20ZengShiraz University of Medical SciencesInternational Journal of Organ Transplantation Medicine2008-64902008-64822012-10-0134157163The Incidence and Risk Factors of De Novo Skin Cancer in the Liver Transplant RecipientsJM Modaresi EsfehM PagadalaR LopezA TabbaD DalalIA HanounehB EghtesadNN ZeinBackground: Liver transplantation (LT) increases the risk of de novo malignancies including skin cancers. However, risk factors for this type of cancers have not been well studied.Objective: To determine the incidence of skin cancer in LT recipients, and to identify the risk factors of this type of cancer.Methods: We identified all adult patients who underwent LT and developed de novo skin cancer post-LT at our institution between 1996 and 2009. We excluded the patients with history of skin cancer prior to LT. We also studied a control group of patients who underwent LT during the same period but did not develop skin cancer; the control group was matched (1:2) for age, gender and geographical place of residence.Results: Over a median (IQR) follow-up of 41.5 (18.0, 98.6) months, 23 (2.3%) of 998 patients developed skin cancer post-LT, of whom 10 were identified with squamous cell carcinoma, 9 with basal cell carcinoma and 4 with melanoma. After adjusting the confounding variables, subjects who had combined liver/kidney transplant had 22 (95% CI: 5.1–99) times higher hazard of skin cancer compared to subjects with LT alone. Furthermore, patients who had non-skin cancer prior to LT had 23 (95% CI: 8.6–60) times higher hazard developing skin cancer after the transplant. Patients with history of alcohol consumption, as the underlying etiology of liver disease, had 4 (95% CI: 1.2–12.9) times higher hazard of developing skin cancer after transplantation. Type or duration of immunosuppression was not associated with increased risk of skin cancer post-LT. The post-LT survival outcome was not affected by the development of de novo skin cancer post-LT.Conclusion: Skin cancer is relatively common in LT recipients and should be monitored, particularly in patients with a history of pretransplant malignancy, recipients of combined liver and kidney transplant or having alcoholic cirrhosis as the underlying cause of liver disease.http://home.sums.ac.ir/~habibzaf/ojs/index.php/IJOTM/article/view/135/238Liver transplantationde novo malignancyskin cancer
spellingShingle JM Modaresi Esfeh
M Pagadala
R Lopez
A Tabba
D Dalal
IA Hanouneh
B Eghtesad
NN Zein
The Incidence and Risk Factors of De Novo Skin Cancer in the Liver Transplant Recipients
International Journal of Organ Transplantation Medicine
Liver transplantation
de novo malignancy
skin cancer
title The Incidence and Risk Factors of De Novo Skin Cancer in the Liver Transplant Recipients
title_full The Incidence and Risk Factors of De Novo Skin Cancer in the Liver Transplant Recipients
title_fullStr The Incidence and Risk Factors of De Novo Skin Cancer in the Liver Transplant Recipients
title_full_unstemmed The Incidence and Risk Factors of De Novo Skin Cancer in the Liver Transplant Recipients
title_short The Incidence and Risk Factors of De Novo Skin Cancer in the Liver Transplant Recipients
title_sort incidence and risk factors of de novo skin cancer in the liver transplant recipients
topic Liver transplantation
de novo malignancy
skin cancer
url http://home.sums.ac.ir/~habibzaf/ojs/index.php/IJOTM/article/view/135/238
work_keys_str_mv AT jmmodaresiesfeh theincidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT mpagadala theincidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT rlopez theincidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT atabba theincidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT ddalal theincidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT iahanouneh theincidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT beghtesad theincidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT nnzein theincidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT jmmodaresiesfeh incidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT mpagadala incidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT rlopez incidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT atabba incidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT ddalal incidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT iahanouneh incidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT beghtesad incidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients
AT nnzein incidenceandriskfactorsofdenovoskincancerinthelivertransplantrecipients